Beneficial Effect of Left Ventricular Remodeling after Early Change of Sacubitril/Valsartan in Patients with Nonischemic Dilated
Authors : Hyue-Mee Kim et al.
Reverse remodelling by sacubitril/valsartan predicts the prognosis in HFrEF fraction
Authors : Mi-Gil Moon et al.
The role of sacubitril/valsartan in the management of cardiac resynchronization therapy non‐responders: a retrospective analysis
Authors : Kyeong-Hyeon Chun et al.
Changes in QRS Duration Are Associated with a Therapeutic Response to Sacubitril–valsartan in Heart Failure with Reduced Ejectio
Authors : Bong-Joon Kim et al.
Sacubitril/valsartan in patients with heart failure with reduced ejection fraction with end-stage of renal disease
Authors : Seonhwa Lee et al.
Real-World Eligibility for Sacubitril/Valsartan in Heart Failure with Reduced Ejection Fraction Patients in Korea: Data from the
Authors : Jaewon Oh et al.
ECG Monitoring of Reactions to Sacubitril-valsartan in Heart Failure with Reduced Ejection Fraction
Authors : Min-Kyung Kang
Eligibility and Usage of Sacubitril/Valsartan in Korea
Authors : Jin-Jin Kim and Jong-Chan Yoon
Angiotensin Receptor Neprilysin Inhibitor for Functional Mitral Regurgitation
Authors : Duk-Hyun Kang et al.